ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,306.04
0.02%
US Tech 100
18,263.60
-0.67%
다우존스 지수
38,852.86
-0.55%
Bitcoin
67,626.16
-0.97%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Forward Pharma AS (FWP)

  7. Forward Pharma AS (FWP) 뉴스

FWP

Forward Pharma AS (FWP)

Forward Pharma AS
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:FWP
일자시간출처헤드라인심볼기업
2023/02/1506:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FWPForward Pharma AS
2023/01/2420:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FWPForward Pharma AS
2023/01/1406:43Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2023/01/0623:16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FWPForward Pharma AS
2022/12/1920:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2022/12/1920:00GlobeNewswire Inc.Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital MarketNASDAQ:FWPForward Pharma AS
2022/12/0704:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2022/12/0704:00GlobeNewswire Inc.Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for ReviewNASDAQ:FWPForward Pharma AS
2022/11/2207:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2022/11/1006:47Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2022/07/0805:35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2022/05/2105:36Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2022/05/0606:40Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2022/05/0305:56Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2022/04/0906:25GlobeNewswire Inc.Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021NASDAQ:FWPForward Pharma AS
2022/02/1502:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FWPForward Pharma AS
2021/12/2720:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FWPForward Pharma AS
2021/12/1407:04Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:FWPForward Pharma AS
2021/12/1407:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FWPForward Pharma AS
2021/10/1306:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2021/09/0720:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2021/09/0623:21GlobeNewswire Inc.Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal HearingNASDAQ:FWPForward Pharma AS
2021/06/0906:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2021/05/2821:00Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2021/05/2806:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2021/05/0419:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2021/04/1606:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2021/04/1606:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
2021/04/1505:40GlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020NASDAQ:FWPForward Pharma AS
2021/04/1505:20Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:FWPForward Pharma AS
 검색 관련기사 보기:NASDAQ:FWP

최근 히스토리

BIT
F29986
Vontobel Financial Produ...
BIT
P1Z2X0
NLBNPIT1Z2X0 20991231 36...
BIT
P20D72
NLBNPIT20D72 20351221 3....
BIT
S24998
SG ISSUER
BIT
P1Q629
BNP Paribas Issuance
BIT
P1J1Z7
BNP Paribas Issuance
BIT
MMS
ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유